Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Doxylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 5/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.83 |
| ▸ | BLM | P54132 | 2/20 | 0.83 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.47 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | SCN1A | P35498 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Doxylamine SCHEMBL30702275 | 1.00 | CHRM2 (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL30116312 | 1.00 | CHRM2 (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL12959067 | 1.00 | CHRM2 (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL17047020 | 0.99 | CHRM2 (0.97) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL160443 | 0.91 | BLM (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL17540680 | 0.91 | BLM (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL1172924 | 0.91 | BLM (1.00) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL17558540 | 0.89 | CHRM2 (0.79) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Doxylamine SCHEMBL21435766 | 0.86 | CHRM2 (0.74) | CHRM2CYP2D6BLMCHRM4CHRM5 | |
| Moxastine SCHEMBL29281 | 0.84 | CHRM2 (0.71) | CHRM2CYP2D6BLMCHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 13722 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075696-A | Application of MSR1 inhibitor in preparation of anti-tumor immunopotentiator | — | 2026-05-26 | — | — | CN | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4716527-A1 | A MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE FREE OF TITANIUM DIOXIDE | Italfarmaco SpA (IT) | 2026-04-01 | — | — | EP | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4706766-A2 | TOPICAL OPHTHALMOLOGICAL COMPOSITIONS | ADS Therapeutics LLC (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4042999-B1 | DRUG ACCOMMODATING DEVICE OF SOLID ORAL FORMULATION, AND ORAL ADMINISTRATION AND DELIVERY APPARATUS COMPRISING SAME | SHANGHAI WD PHARMACEUTICAL CO LTD (CN) | 2026-03-04 | — | — | EP | claimed |
| EP-4691492-A2 | LIQUID COMPOSITIONS | Kenvue Brands LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| US-4749720-A | ANALGESICS AND ANTIHISTAMINES | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| US-4749697-A | ADMINISTERING MIXTURES OF PIROXICAM, SUDOXICAM, OR ISOXICAM WITH ANTIHISTAMINE | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| US-4749723-A | ADMINISTERING MEFENAMIC ACID, SODIUM MECLOFENAMATE OR SALT WITH ANTIHISTAMINE | ANALGESIC ASSOCIATES (US) | 1988-06-07 | — | — | US | claimed |
| CN-87104429-A | Controlled release matrix for pharmaceutical agents | — | 1988-01-27 | — | — | CN | claimed |
| EP-0201537-A4 | NOVEL USE OF ANTI-NAUSEA AND ANTI-EMETIC PHARMAZEUTICAL AGENTS. | NASTECH PHARM CO (US) | 1987-07-06 | — | — | EP | claimed |
| EP-0201537-A1 | NOVEL USE OF ANTI-NAUSEA AND ANTI-EMETIC PHARMAZEUTICAL AGENTS. | NASTECH PHARM CO (US) | 1986-11-20 | — | — | EP | claimed |
| US-4619934-A | AND ANTIHISTAMINE, DECONGESTANT, ANTITUSSIVE OR EXPECTORANT | ANALGESIC ASSOCIATES (US) | 1986-10-28 | — | — | US | claimed |
| EP-0180597-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. | SUNSHINE ABRAHAM (US) | 1986-05-14 | — | — | EP | claimed |
| WO-1986002553-A1 | NOVEL METHOD OF ADMINISTERING ANTI-NAUSEA AND ANTI-EMETIC PHARMACEUTICAL AGENTS AND NOVEL DOSAGE FORMS CONTAINING SAME | NASTECH PHARMACEUTICAL COMPANY, INC. (US) | 1986-05-09 | — | — | WO | claimed |
| WO-1985004589-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | SUNSHINE ABRAHAM | 1985-10-24 | — | — | WO | claimed |